BIOREM today announced its results for the three and nine-month periods ended September 30, 2024. BIOREM’s complete Third quarter financial statements and […]
BIOREM today announced its results for the three and six-month periods ended June 30, 2024. BIOREM’s complete second quarter financial statements and […]
BIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order Backlog BIOREM today announced results for the three month period […]
Guelph, Ontario – November 29, 2023 – BIOREM Inc. (TSX-V: BRM) (“BIOREM” or “The Company”) today announced its results for the three […]
Biorem Reports Second Quarter Results and RecordOrder Backlog Guelph, Ontario – August 23, 2023 – BIOREM Inc. (TSX-V: BRM) (“BIOREM” or “The […]
BIOREM Inc announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors, of the […]
Biorem today announced results for the three month period ended March 31, 2023. Biorem’s complete 2023 first quarter financial statements and MD&A […]
Biorem today announced its results for the three and twelve-month periods ended December 31, 2022. Biorem’s complete fiscal 2022 year-end financial statements […]
Closing of Transaction to Purchase Common Shares for Cancellation BIOREM is pleased to announce that it has completed the transaction to purchase […]